Q3 2023 Holdings
Filed 2023-11-13 | 105 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cava Group Inc(CAVA) | COM | 148929102 | $980.4M | 32,007,990 | 87.6% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $72.7M | 403,934 | 6.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $44.7M | 1,518,831 | 4.0% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $7.8M | 1,000,000 | 0.7% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $5.9M | 2,046,517 | 0.5% |
| Adagene Inc(ADAG) | ADS | 005329107 | $1.5M | 1,000,000 | 0.1% |
| Amazon COM Inc(AMZN) | COM | 023135106 | $1.5M | 12,000 | 0.1% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONSORED ADR | 00653A107 | $884.0K | 1,133,775 | 0.1% |
| Alphabet Inc(GOOGL) | CAP STK CL A | 02079K305 | $720.0K | 5,500 | 0.1% |
| Advanced Micro Devices Inc(AMD) | COM | 007903107 | $617.0K | 6,000 | 0.1% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $504.0K | 105,347 | 0.0% |
| Cyclerion Therapeutics Inc(CYCN) | COM | 23255M204 | $473.0K | 138,403 | 0.0% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $264.0K | 10,975 | 0.0% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $166.0K | 936 | 0.0% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $146.0K | 5,440 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $128.1K | 117,553,284 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $88.2K | 2,024,226 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $70.0K | 2,529,737 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $64.3K | 9,059,507 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $63.3K | 1,664,572 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $49.4K | 4,062,567 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $49.0K | 2,138,188 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $42.0K | 1,816,620 | 0.0% |
| Neumora Therapeutics Inc(NMRA) | COM | 640979100 | $39.5K | 2,802,702 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $35.8K | 1,638,858 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR)Call | COM | 60468T105 | $30.5K | 700,000 | 0.0% |
| Acelyrin Inc | COM | 00445A100 | $25.1K | 2,469,279 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $25.1K | 1,805,346 | 0.0% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $24.6K | 2,500,000 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $24.0K | 1,512,113 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $21.1K | 2,522,244 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $18.4K | 2,018,056 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $17.7K | 15,631,235 | 0.0% |
| SEA LTD(SE) | SPONSORED ADS | 81141R100 | $17.4K | 397,000 | 0.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $16.6K | 802,899 | 0.0% |
| Allovir Inc | COM | 019818103 | $14.2K | 6,597,167 | 0.0% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $14.1K | 500,000 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $14.1K | 405,239 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $13.7K | 1,193,030 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $12.9K | 8,589,064 | 0.0% |
| Rayzebio Inc | COM | 75525N107 | $12.3K | 555,556 | 0.0% |
| Geron Corp(GERN) | COM | 374163103 | $11.8K | 5,565,889 | 0.0% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $11.7K | 1,000,000 | 0.0% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $11.6K | 3,663,104 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $11.5K | 2,000,000 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $10.7K | 2,814,191 | 0.0% |
| Seer Inc(SEER) | COM CL A | 81578P106 | $10.5K | 4,750,000 | 0.0% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $10.3K | 1,908,135 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $9.7K | 9,136,635 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $9.6K | 2,500,000 | 0.0% |